_id
6914811cccc777a4e85d92f4
Ticker
NEUP
Name
Neuphoria Therapeutics Inc
Exchange
NASDAQ
Address
100 Summit Drive, Burlington, MA, United States, 01803
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.neuphoriatx.com
Description
Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105 for the treatment of cancer. In addition, it develops NextGen, which is in preclinical trial for the treatment of multiple central nervous system indications; and Kv3.1/3.2 agonist, which is in preclinical trial to treat potential cognitive deficits and negative symptoms/social withdrawal in schizophrenia and autism spectrum disorders. The company has a collaboration with Merck & Co., Inc. to develop a7 receptor positive allosteric modulators targeting cognitive dysfunction associated with alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Burlington, Massachusetts.
Last Close
3.91
Volume
31222
Current Price
4.19
Change
-0.06
Last Updated
2026-01-05T11:19:30.479Z
Image
data:image/webp;base64,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
Ipo Date
2024-12-23T00:00:00.000Z
Market Cap
20541396
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
9.7667
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
250826
Gross Profit
-250826
Operating Expenses
8301126
Operating Income
-8551953
Interest Expense
-
Pretax Income
-15040188
Net Income
-14987549
Eps
-6.672799908818352
Dividends Per Share
-
Shares Outstanding
5377329
Income Tax Expense
-52638
EBITDA
-14789369
Operating Margin
-
Total Other Income Expense Net
-6488235
Cash
13649638
Short Term Investments
-
Receivables
1758
Inventories
-
Total Current Assets
13952279
Property Plant Equipment
77792
Total Assets
27343913
Payables
1370728
Short Term Debt
85210
Long Term Debt
-
Total Liabilities
14833726
Equity
12510187
Bs_currency_symbol
USD
Depreciation
165792
Change In Working Capital
1396787
Cash From Operations
-3794648
Capital Expenditures
2
Cash From Investing
-
Cash From Financing
3253615
Net Change In Cash
-3316548
Cf_currency_symbol
USD
PE
-
PB
0.7522682546631797
ROE
-119.80275754471137
ROA
-54.81128103355215
FCF
-3794650
Fcf Percent
-
Piotroski FScore
1
Health Score
32
Deep Value Investing Score
5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
3.5
Quality Investing Score
2
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
250826
Quarters > 0 > income Statement > gross Profit
-250826
Quarters > 0 > income Statement > operating Expenses
8301126
Quarters > 0 > income Statement > operating Income
-8551953
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-15040188
Quarters > 0 > income Statement > net Income
-14987549
Quarters > 0 > income Statement > eps
-6.672799908818352
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2246066
Quarters > 0 > income Statement > income Tax Expense
-52638
Quarters > 0 > income Statement > EBITDA
-14789369
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-6488235
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
13649638
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1758
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
13952279
Quarters > 0 > balance Sheet > property Plant Equipment
77792
Quarters > 0 > balance Sheet > total Assets
27343913
Quarters > 0 > balance Sheet > payables
1370728
Quarters > 0 > balance Sheet > short Term Debt
85210
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
14833726
Quarters > 0 > balance Sheet > equity
12510187
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-9906504
Quarters > 0 > cash Flow > depreciation
165792
Quarters > 0 > cash Flow > change In Working Capital
1396787
Quarters > 0 > cash Flow > cash From Operations
-3794648
Quarters > 0 > cash Flow > capital Expenditures
2
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
3253615
Quarters > 0 > cash Flow > net Change In Cash
-3316548
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-6.672799908818352
Quarters > 0 > ratios > PB
0.7522682546631797
Quarters > 0 > ratios > ROE
-119.80275754471137
Quarters > 0 > ratios > ROA
-54.81128103355215
Quarters > 0 > ratios > FCF
-3794650
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
32
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
-15662715
Quarters > 1 > income Statement > cost Of Revenue
331144
Quarters > 1 > income Statement > gross Profit
-15332000
Quarters > 1 > income Statement > operating Expenses
16767913760
Quarters > 1 > income Statement > operating Income
-1133796489
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-846310260
Quarters > 1 > income Statement > net Income
-378145651
Quarters > 1 > income Statement > eps
-233.00268589286992
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1622924
Quarters > 1 > income Statement > income Tax Expense
-468164423
Quarters > 1 > income Statement > EBITDA
-846807339
Quarters > 1 > income Statement > operating Margin
7238.824743985957
Quarters > 1 > income Statement > total Other Income Expense Net
287486694
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
14210745000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
11948000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
15040831000
Quarters > 1 > balance Sheet > property Plant Equipment
105383000
Quarters > 1 > balance Sheet > total Assets
28589614000
Quarters > 1 > balance Sheet > payables
1154369000
Quarters > 1 > balance Sheet > short Term Debt
116314000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
9587040000
Quarters > 1 > balance Sheet > equity
19002574000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-378146161
Quarters > 1 > cash Flow > depreciation
662392735
Quarters > 1 > cash Flow > change In Working Capital
2169517
Quarters > 1 > cash Flow > cash From Operations
73566548
Quarters > 1 > cash Flow > capital Expenditures
3
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
1527447595
Quarters > 1 > cash Flow > net Change In Cash
14271570518
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-233.00268589286992
Quarters > 1 > ratios > PB
0.00035784897140776826
Quarters > 1 > ratios > ROE
-1.9899706797615946
Quarters > 1 > ratios > ROA
-1.3226679135996728
Quarters > 1 > ratios > FCF
73566545
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-4.696921638426033
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
23874300
Quarters > 2 > income Statement > cost Of Revenue
263303
Quarters > 2 > income Statement > gross Profit
23610996
Quarters > 2 > income Statement > operating Expenses
4547856
Quarters > 2 > income Statement > operating Income
19063139
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
17795863
Quarters > 2 > income Statement > net Income
17925080
Quarters > 2 > income Statement > eps
0.07659906686386247
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
234011728
Quarters > 2 > income Statement > income Tax Expense
-129217
Quarters > 2 > income Statement > EBITDA
18059168
Quarters > 2 > income Statement > operating Margin
79.84794946867552
Quarters > 2 > income Statement > total Other Income Expense Net
-1267276
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
17045000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
24592
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
17090000
Quarters > 2 > balance Sheet > property Plant Equipment
126836
Quarters > 2 > balance Sheet > total Assets
30713000
Quarters > 2 > balance Sheet > payables
745336
Quarters > 2 > balance Sheet > short Term Debt
153138
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4716000
Quarters > 2 > balance Sheet > equity
25997000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
11262161
Quarters > 2 > cash Flow > depreciation
165431
Quarters > 2 > cash Flow > change In Working Capital
-642517
Quarters > 2 > cash Flow > cash From Operations
11453452
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
1162501
Quarters > 2 > cash Flow > net Change In Cash
12700922
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.07659906686386247
Quarters > 2 > ratios > PB
37.716241886371506
Quarters > 2 > ratios > ROE
68.95057121975613
Quarters > 2 > ratios > ROA
58.36316869078241
Quarters > 2 > ratios > FCF
11453452
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.47973980388953813
Quarters > 2 > health Score
85
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1070543
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
662715
Quarters > 3 > income Statement > operating Expenses
7053157
Quarters > 3 > income Statement > operating Income
-5982614
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-3120513
Quarters > 3 > income Statement > net Income
-3139266
Quarters > 3 > income Statement > eps
-0.013414994311738085
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
234011728
Quarters > 3 > income Statement > income Tax Expense
18753
Quarters > 3 > income Statement > EBITDA
-3120519
Quarters > 3 > income Statement > operating Margin
-558.8392058983152
Quarters > 3 > income Statement > total Other Income Expense Net
2862101
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
4345000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
35561
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
4399000
Quarters > 3 > balance Sheet > property Plant Equipment
152202
Quarters > 3 > balance Sheet > total Assets
18168000
Quarters > 3 > balance Sheet > payables
1531000
Quarters > 3 > balance Sheet > short Term Debt
149577
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
4420000
Quarters > 3 > balance Sheet > equity
13748000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1943000
Quarters > 3 > cash Flow > depreciation
166121
Quarters > 3 > cash Flow > change In Working Capital
-328000
Quarters > 3 > cash Flow > cash From Operations
-3358000
Quarters > 3 > cash Flow > capital Expenditures
0.79
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-107096
Quarters > 3 > cash Flow > net Change In Cash
-3746000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.013414994311738085
Quarters > 3 > ratios > PB
71.32012949665406
Quarters > 3 > ratios > ROE
-22.83434681408205
Quarters > 3 > ratios > ROA
-17.279095112285336
Quarters > 3 > ratios > FCF
-3358000.79
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-3.1367266798250983
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2025-06-30
Annuals > 0 > income Statement > revenue
23953671
Annuals > 0 > income Statement > cost Of Revenue
1014645
Annuals > 0 > income Statement > gross Profit
22939025
Annuals > 0 > income Statement > operating Expenses
24667256
Annuals > 0 > income Statement > operating Income
-1728231
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1282673
Annuals > 0 > income Statement > net Income
-565773
Annuals > 0 > income Statement > eps
-0.34861336698452916
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1622924
Annuals > 0 > income Statement > income Tax Expense
-716899
Annuals > 0 > income Statement > EBITDA
-268025
Annuals > 0 > income Statement > operating Margin
-7.214889943174055
Annuals > 0 > income Statement > total Other Income Expense Net
445558
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
14210745000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
11948000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
15040831000
Annuals > 0 > balance Sheet > property Plant Equipment
105383000
Annuals > 0 > balance Sheet > total Assets
28589614000
Annuals > 0 > balance Sheet > payables
1154369000
Annuals > 0 > balance Sheet > short Term Debt
116314000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
9587040000
Annuals > 0 > balance Sheet > equity
19002574000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-369632000
Annuals > 0 > cash Flow > depreciation
662890000
Annuals > 0 > cash Flow > change In Working Capital
-496826
Annuals > 0 > cash Flow > cash From Operations
77229000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
1528276000
Annuals > 0 > cash Flow > net Change In Cash
1601755000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.34861336698452916
Annuals > 0 > ratios > PB
0.0003262489429063663
Annuals > 0 > ratios > ROE
-0.0029773492791029255
Annuals > 0 > ratios > ROA
-0.001978945920710927
Annuals > 0 > ratios > FCF
77229000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
3.2240987195657818
Annuals > 0 > health Score
49
Annuals > 1 > quarter
2024-06-30
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
992563
Annuals > 1 > income Statement > gross Profit
-992563
Annuals > 1 > income Statement > operating Expenses
25794112
Annuals > 1 > income Statement > operating Income
-26786676
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-23324048
Annuals > 1 > income Statement > net Income
-23193321
Annuals > 1 > income Statement > eps
-0.15482801584485567
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
149800544
Annuals > 1 > income Statement > income Tax Expense
-130726
Annuals > 1 > income Statement > EBITDA
-22331489
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
3462627
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
12608000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
126884
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
13194000
Annuals > 1 > balance Sheet > property Plant Equipment
218969
Annuals > 1 > balance Sheet > total Assets
27649000
Annuals > 1 > balance Sheet > payables
2244000
Annuals > 1 > balance Sheet > short Term Debt
155110
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
10159000
Annuals > 1 > balance Sheet > equity
17490000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-15492000
Annuals > 1 > cash Flow > depreciation
662991
Annuals > 1 > cash Flow > change In Working Capital
1455000
Annuals > 1 > cash Flow > cash From Operations
-14681000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
15109000
Annuals > 1 > cash Flow > net Change In Cash
504991
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.15482801584485567
Annuals > 1 > ratios > PB
32.718014755860494
Annuals > 1 > ratios > ROE
-132.60903945111494
Annuals > 1 > ratios > ROA
-83.88484574487323
Annuals > 1 > ratios > FCF
-14681000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2023-06-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
671419
Annuals > 2 > income Statement > gross Profit
-671419
Annuals > 2 > income Statement > operating Expenses
21584292
Annuals > 2 > income Statement > operating Income
-22255712
Annuals > 2 > income Statement > interest Expense
14084
Annuals > 2 > income Statement > pretax Income
-22215840
Annuals > 2 > income Statement > net Income
-21646954
Annuals > 2 > income Statement > eps
-0.17686197607152956
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
122394618
Annuals > 2 > income Statement > income Tax Expense
-568886
Annuals > 2 > income Statement > EBITDA
-21544418
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
39870
Annuals > 2 > income Statement > currency_symbol
AUD
Annuals > 2 > balance Sheet > cash
8056393
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
283624
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
8870859
Annuals > 2 > balance Sheet > property Plant Equipment
221661
Annuals > 2 > balance Sheet > total Assets
19393769
Annuals > 2 > balance Sheet > payables
958064
Annuals > 2 > balance Sheet > short Term Debt
97903
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4742438
Annuals > 2 > balance Sheet > equity
14651331
Annuals > 2 > balance Sheet > currency_symbol
AUD
Annuals > 2 > cash Flow > net Income
-14382339
Annuals > 2 > cash Flow > depreciation
446094
Annuals > 2 > cash Flow > change In Working Capital
3083746
Annuals > 2 > cash Flow > cash From Operations
-9846030
Annuals > 2 > cash Flow > capital Expenditures
0.25
Annuals > 2 > cash Flow > cash From Investing
317414
Annuals > 2 > cash Flow > cash From Financing
2595378
Annuals > 2 > cash Flow > net Change In Cash
-15024480
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.17686197607152956
Annuals > 2 > ratios > PB
31.91160180327644
Annuals > 2 > ratios > ROE
-147.7473548307659
Annuals > 2 > ratios > ROA
-111.6180872320383
Annuals > 2 > ratios > FCF
-9846030.25
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2022-06-30
Annuals > 3 > income Statement > revenue
277892.5
Annuals > 3 > income Statement > cost Of Revenue
15998999
Annuals > 3 > income Statement > gross Profit
181356
Annuals > 3 > income Statement > operating Expenses
27709186
Annuals > 3 > income Statement > operating Income
-28600707
Annuals > 3 > income Statement > interest Expense
18485
Annuals > 3 > income Statement > pretax Income
-29243316
Annuals > 3 > income Statement > net Income
-22936204
Annuals > 3 > income Statement > eps
-0.20337259269056177
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
112779228
Annuals > 3 > income Statement > income Tax Expense
-6307110
Annuals > 3 > income Statement > EBITDA
-28027353
Annuals > 3 > income Statement > operating Margin
-10292.003922380058
Annuals > 3 > income Statement > total Other Income Expense Net
-642608.5
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
23089577
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
4666990
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
28761657
Annuals > 3 > balance Sheet > property Plant Equipment
464015
Annuals > 3 > balance Sheet > total Assets
44927475
Annuals > 3 > balance Sheet > payables
1070992
Annuals > 3 > balance Sheet > short Term Debt
110093
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
5776593
Annuals > 3 > balance Sheet > equity
39150881
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-14968464
Annuals > 3 > cash Flow > depreciation
763174
Annuals > 3 > cash Flow > change In Working Capital
-3853643
Annuals > 3 > cash Flow > cash From Operations
-14965801
Annuals > 3 > cash Flow > capital Expenditures
1062
Annuals > 3 > cash Flow > cash From Investing
427675
Annuals > 3 > cash Flow > cash From Financing
18570539
Annuals > 3 > cash Flow > net Change In Cash
3484541
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.20337259269056177
Annuals > 3 > ratios > PB
11.004009104162943
Annuals > 3 > ratios > ROE
-58.584132500109
Annuals > 3 > ratios > ROA
-51.05162041712783
Annuals > 3 > ratios > FCF
-14966863
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-53.85846325467582
Annuals > 3 > health Score
26
Valuation > metrics > PE
-6.672799908818352
Valuation > metrics > PB
0.7522682546631797
Valuation > final Score
70
Valuation > verdict
24.8% Undervalued
Profitability > metrics > ROE
-119.80275754471137
Profitability > metrics > ROA
-107.42007811053665
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1857317560480911
Risk > metrics > Interest Coverage
-34.09611313337506
Risk > final Score
-106
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.583017271339852
Liquidity > metrics > Quick Ratio
9.583017271339852
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
40
Prev Valuations > 2
20
Prev Profitabilities > 0
30
Prev Profitabilities > 1
100
Prev Profitabilities > 2
0
Prev Risks > 0
-9076
Prev Risks > 1
100
Prev Risks > 2
-3988349
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:16:30.720Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-4.41
Earnings History > 0 > eps Estimate
-1.31
Earnings History > 0 > eps Difference
-3.1
Earnings History > 0 > surprise Percent
-236.6412
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-5.55
Earnings History > 1 > eps Estimate
-3.83
Earnings History > 1 > eps Difference
-1.72
Earnings History > 1 > surprise Percent
-44.9086
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-20
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
6.55
Earnings History > 2 > eps Estimate
6.44
Earnings History > 2 > eps Difference
0.11
Earnings History > 2 > surprise Percent
1.7081
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.2337
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-27
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0034
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-21
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
-0.6608
Earnings History > 5 > eps Difference
0.6608
Earnings History > 5 > surprise Percent
100
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-29
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-33.9821
Earnings History > 6 > eps Estimate
-0.58
Earnings History > 6 > eps Difference
-33.4021
Earnings History > 6 > surprise Percent
-5758.9828
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-63.7529
Earnings History > 7 > eps Estimate
-0.63
Earnings History > 7 > eps Difference
-63.1229
Earnings History > 7 > surprise Percent
-10019.5079
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-29
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0
Earnings History > 8 > eps Estimate
-0.59
Earnings History > 8 > eps Difference
0.59
Earnings History > 8 > surprise Percent
100
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-23
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
-0.26
Earnings History > 9 > eps Difference
0.26
Earnings History > 9 > surprise Percent
100
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0
Earnings History > 10 > eps Estimate
-0.46
Earnings History > 10 > eps Difference
0.46
Earnings History > 10 > surprise Percent
100
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.6642
Earnings History > 11 > eps Estimate
-0.66
Earnings History > 11 > eps Difference
-0.0042
Earnings History > 11 > surprise Percent
-0.6364
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.6992
Earnings History > 12 > eps Estimate
-0.7
Earnings History > 12 > eps Difference
0.0008
Earnings History > 12 > surprise Percent
0.1143
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-25
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-97.2
Earnings History > 13 > eps Estimate
-97.2
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-06-01
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-102.6
Earnings History > 14 > eps Estimate
-102.6
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-23
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.51
Earnings History > 15 > eps Estimate
-0.51
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-12-01
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.8096
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.8096
Earnings History > 16 > surprise Percent
-
Neuphoria Therapeutics Inc., a clinical stage biopharmaceutical company, discovers and develops novel allosteric ion channel modulators for the treatment of central nervous system disorders in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7 for the treatment of social anxiety disorder; and is phase 2b to treat post-traumatic stress disorder. The company also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105 for the treatment of cancer. In addition, it develops NextGen, which is in preclinical trial for the treatment of multiple central nervous system indications; and Kv3.1/3.2 agonist, which is in preclinical trial to treat potential cognitive deficits and negative symptoms/social withdrawal in schizophrenia and autism spectrum disorders. The company has a collaboration with Merck & Co., Inc. to develop a7 receptor positive allosteric modulators targeting cognitive dysfunction associated with alzheimer's disease and other central nervous system conditions. The company was formerly known as Bionomics Limited and changed its name Neuphoria Therapeutics Inc. in December 2024. Neuphoria Therapeutics Inc. was incorporated in 1996 and is based in Burlington, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ARetail Trends: What are BCAXs technical support levels - 2025 Big Picture & AI Powered Market Entry Ideas baoquankhu1.vn
Read more →Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value - MSN
1/19/2026
Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value MSN
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$9.7667
Analyst Picks
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Neuphoria Therapeutics Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-4.41
EPS Estimate
-1.31
EPS Difference
-3.1
Surprise Percent
-236.6412%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.